Header
Header
Article

Advancing alcohol-related liver disease: from novel biomarkers to refining selection for liver transplantation


  • Ayares, G. et al. Public health measures and prevention of alcohol-associated liver disease. J. Clin. Exp. Hepatol. 12, 1480–1491 (2022).

    Article 

    Google Scholar
     

  • Griswold, M. G. et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 392, 1015–1035 (2018).

    Article 

    Google Scholar
     

  • Kwong, A. J. et al. OPTN/SRTR 2020 Annual Data Report: Liver. Am. J. Transplant 22 (Suppl. 2), 204–309 (2022).

    Article 

    Google Scholar
     

  • Arab, J. P. et al. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study. J. Hepatol. 75, 1026–1033 (2021).

    Article 

    Google Scholar
     

  • Niu, L. et al. Noninvasive proteomic biomarkers for alcohol-related liver disease. Nat. Med. 28, 1277–1287 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Duan, Y. et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature 575, 505–511 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Duan, Y. et al. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. Nat. Commun. 12, 7172 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Mathurin, P. et al. Early liver transplantation for severe alcoholic hepatitis. N. Engl. J. Med. 365, 1790–1800 (2011).

    Article 
    CAS 

    Google Scholar
     

  • Louvet, A. et al. Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study. Lancet Gastroenterol. Hepatol. 7, 416–425 (2022).

    Article 

    Google Scholar
     



  • Source link

    Back to top button